Scientist Home Future Health Financials
This page shows Scientist Home Future Health (SHFH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
External funding is doing the work of a business model here, because overhead far exceeds a very small revenue base.
With revenue of$204K , operations consumed-$248K of cash, so the reported loss is also a cash loss. The gap was bridged by$376K of financing inflow, meaning the company is currently capital-supported rather than self-funded and is using outside cash to cover both operations and investment spend.
The main strain is overhead load, not weak gross economics alone: a
The balance sheet is liability-heavy and the short-term cushion is thin: the current ratio was 0.9x and cash was only
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Scientist Home Future Health's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Scientist Home Future Health has an operating margin of -113.6%, meaning the company retains $-114 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses.
Scientist Home Future Health has elevated debt relative to equity (D/E of 4.68), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 6/100, reflecting increased financial risk.
Scientist Home Future Health's current ratio of 0.90 is below the typical benchmark, resulting in a score of 13/100. This tight liquidity could limit financial flexibility if cash inflows slow.
While Scientist Home Future Health generated -$248K in operating cash flow, capex of $75K consumed most of it, leaving -$323K in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Scientist Home Future Health generates a -204.4% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100.
For every $1 of reported earnings, Scientist Home Future Health generates $1.07 in operating cash flow (-$248K OCF vs -$232K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Scientist Home Future Health generated $204K in revenue in fiscal year 2025.
Scientist Home Future Health's EBITDA was -$230K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
Scientist Home Future Health reported -$232K in net income in fiscal year 2025.
Scientist Home Future Health earned $-0.01 per diluted share (EPS) in fiscal year 2025.
Cash & Balance Sheet
Scientist Home Future Health generated -$323K in free cash flow in fiscal year 2025, representing cash available after capex.
Scientist Home Future Health held $69K in cash against $0 in long-term debt as of fiscal year 2025.
Scientist Home Future Health had 24M shares outstanding in fiscal year 2025.
Margins & Returns
Scientist Home Future Health's gross margin was 40.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs.
Scientist Home Future Health's operating margin was -113.6% in fiscal year 2025, reflecting core business profitability.
Scientist Home Future Health's net profit margin was -113.6% in fiscal year 2025, showing the share of revenue converted to profit.
Scientist Home Future Health's ROE was -204.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.
Capital Allocation
Scientist Home Future Health invested $75K in capex in fiscal year 2025, funding long-term assets and infrastructure.
SHFH Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|
| Revenue | $189K+114.3% | $88K+122.4% | $40K+25.5% | $32K-29.6% | $45K | N/A | $59K |
| Cost of Revenue | $0+100.0% | -$40K-271.9% | $24K+30.7% | $18K | $0 | N/A | $33K |
| Gross Profit | $59K+81.3% | $33K+102.8% | $16K+18.7% | $14K-31.2% | $20K | N/A | $26K |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $161K-13.0% | $185K+189.9% | $64K+23.7% | $52K+307.1% | $13K | N/A | $24K |
| Operating Income | -$102K+33.2% | -$153K-219.2% | -$48K-25.4% | -$38K-645.4% | $7K | N/A | $2K |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $0 | $0 | $0+100.0% | -$935-200.0% | $935 | N/A | $2K |
| Net Income | -$102K+33.2% | -$153K-219.2% | -$48K-28.6% | -$37K-714.2% | $6K | N/A | $175 |
| EPS (Diluted) | $0.00 | N/A | $0.00 | $0.00 | $0.00 | N/A | $0.00 |
SHFH Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|
| Total Assets | $559K-13.3% | $644K-10.9% | $723K+530.3% | $115K+485.4% | $20K-7.8% | $21K-54.2% | $46K |
| Current Assets | $132K-31.4% | $192K-41.0% | $326K+183.9% | $115K+485.4% | $20K-7.8% | $21K | N/A |
| Cash & Equivalents | $15K-77.7% | $69K-75.0% | $276K+147.4% | $111K+590.3% | $16K-13.4% | $19K-1.8% | $19K |
| Inventory | $31K-7.7% | $34K+1608.0% | $2K-40.2% | $3K-3.8% | $3K+31.7% | $3K | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $547K+3.1% | $531K+16.4% | $456K+621.7% | $63K+222.9% | $20K-28.2% | $27K-26.8% | $37K |
| Current Liabilities | $252K+17.6% | $214K+73.8% | $123K+95.3% | $63K+222.9% | $20K-28.2% | $27K | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $11K-89.9% | $113K-57.5% | $267K+418.1% | $52K+190763.0% | $27+100.4% | -$6K-165.9% | $9K |
| Retained Earnings | -$349K-41.4% | -$247K-162.5% | -$94K-103.7% | -$46K-417.1% | -$9K+40.4% | -$15K | N/A |
SHFH Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$72K+48.3% | -$139K-39.7% | -$99K-1776.6% | -$5K-9.6% | -$5K-155.7% | $9K+191.7% | -$9K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $19K+140.5% | $8K-97.1% | $265K+163.9% | $101K+4188.7% | $2K+126.0% | -$9K-131.7% | $28K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
SHFH Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 31.3%-5.7pp | 37.0%-3.6pp | 40.6%-2.3pp | 42.9%-1.0pp | 43.9% | N/A | 44.5% |
| Operating Margin | -54.1%+119.3pp | -173.4%-52.6pp | -120.8%+0.1pp | -120.9%-136.5pp | 15.6% | N/A | 3.3% |
| Net Margin | -54.1%+119.3pp | -173.4%-52.6pp | -120.8%-2.9pp | -117.9%-131.5pp | 13.5% | N/A | 0.3% |
| Return on Equity | -893.2%-758.6pp | -134.7%-116.8pp | -17.9%+54.3pp | -72.2%-22513.0pp | 22440.7% | N/A | 1.9% |
| Return on Assets | -18.3%+5.4pp | -23.7%-17.1pp | -6.6%+25.8pp | -32.4%-63.4pp | 30.9% | N/A | 0.4% |
| Current Ratio | 0.52-0.4 | 0.90-1.7 | 2.64+0.8 | 1.82+0.8 | 1.00+0.2 | 0.78 | N/A |
| Debt-to-Equity | 47.90+43.2 | 4.68+3.0 | 1.71+0.5 | 1.23-723.5 | 724.74+729.3 | -4.53-8.6 | 4.08 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: The current ratio is below 1.0 (0.90), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Frequently Asked Questions
What is Scientist Home Future Health's annual revenue?
Scientist Home Future Health (SHFH) reported $204K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is Scientist Home Future Health profitable?
No, Scientist Home Future Health (SHFH) reported a net income of -$232K in fiscal year 2025, with a net profit margin of -113.6%.
What is Scientist Home Future Health's EBITDA?
Scientist Home Future Health (SHFH) had EBITDA of -$230K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Scientist Home Future Health's gross margin?
Scientist Home Future Health (SHFH) had a gross margin of 40.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Scientist Home Future Health's operating margin?
Scientist Home Future Health (SHFH) had an operating margin of -113.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Scientist Home Future Health's net profit margin?
Scientist Home Future Health (SHFH) had a net profit margin of -113.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Scientist Home Future Health's return on equity (ROE)?
Scientist Home Future Health (SHFH) has a return on equity of -204.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Scientist Home Future Health's free cash flow?
Scientist Home Future Health (SHFH) generated -$323K in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Scientist Home Future Health's operating cash flow?
Scientist Home Future Health (SHFH) generated -$248K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Scientist Home Future Health's total assets?
Scientist Home Future Health (SHFH) had $644K in total assets as of fiscal year 2025, including both current and long-term assets.
What are Scientist Home Future Health's capital expenditures?
Scientist Home Future Health (SHFH) invested $75K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Scientist Home Future Health's current ratio?
Scientist Home Future Health (SHFH) had a current ratio of 0.90 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Scientist Home Future Health's debt-to-equity ratio?
Scientist Home Future Health (SHFH) had a debt-to-equity ratio of 4.68 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Scientist Home Future Health's return on assets (ROA)?
Scientist Home Future Health (SHFH) had a return on assets of -36.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Scientist Home Future Health's cash runway?
Based on fiscal year 2025 data, Scientist Home Future Health (SHFH) had $69K in cash against an annual operating cash burn of $248K. This gives an estimated cash runway of approximately 3 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Are Scientist Home Future Health's earnings high quality?
Scientist Home Future Health (SHFH) has an earnings quality ratio of 1.07x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Scientist Home Future Health?
Scientist Home Future Health (SHFH) scores 3 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.